AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.140

-0.005-3.45%

Volume:67.58K

Turnover:9.32K

Market Cap:31.80M

PE:-1.58

High:0.145

Open:0.135

Low:0.135

Close:0.145

52wk High:0.690

52wk Low:0.135

Shares:227.14M

Float Shares:188.02M

Volume Ratio:1.26

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.089

EPS(LYR):-0.089

ROE:-36.16%

ROA:-15.00%

PB:0.63

PE(LYR):-1.58

Loading ...

Overview Company News Filings

Genetic Signatures Ltd-Gss Appoints Anne Lockwood as Interim Managing Director

THOMSON REUTERS

Genetic Signatures Ltd-Genetic Signatures Appoints Maria Halasz as CEO

THOMSON REUTERS

Slammed 26% Genetic Signatures Limited (ASX:GSS) Screens Well Here But There Might Be A Catch

Simply Wall St.

BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales

BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 Million

Genetic Signatures Ltd - Q2 Sales of a$3.3 Million

THOMSON REUTERS

We're Not Very Worried About Genetic Signatures' (ASX:GSS) Cash Burn Rate

Simply Wall St.

Genetic Signatures CEO to Step Down, Shares Fall 9%

MT Newswires Live

BRIEF-Genetic Signatures Says CEO Allison Rossiter To Leave

Genetic Signatures Ltd - CEO Allison Rossiter Informed Board of Leaving

THOMSON REUTERS

Genetic Signatures Chief Financial, Operating Officer Resigns

MT Newswires Live

BRIEF-Genetic Signatures Announces Resignation Of CFO Karl Pechmann

Genetic Signatures Ltd-Resignation of Chief Financial Officer

THOMSON REUTERS

Even With A 26% Surge, Cautious Investors Are Not Rewarding Genetic Signatures Limited's (ASX:GSS) Performance Completely

Simply Wall St.

Genetic Signatures Updates CEO Remuneration

MT Newswires Live

Genetic Signatures Ltd-Chief Executive Officer Remuneration Update

THOMSON REUTERS

Genetic Signatures Reports Regional Success of EasyScreen Gastrointestinal Parasite Detection Kit

BUZZ-Australia's Genetic Signatures set for best day on sales growth

BRIEF-Genetic Signatures Says Quarterly Sales Reach A$5.4 Million

Genetic Signatures Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GSS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.14,"timestamp":1770700320000,"preClose":0.145,"halted":0,"volume":67580,"delay":0,"changeRate":-0.034482758620689495,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0887,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"02-10 16:12:00 AEDT","open":0.135,"high":0.145,"low":0.135,"amount":9324,"amplitude":0.068966,"askPrice":0.14,"askSize":80627,"bidPrice":0.135,"bidSize":6199,"shortable":3,"etf":0,"ttmEps":-0.0887,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.145,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.25997,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-15.00%","roe":"-36.16%","lyrEps":-0.088679,"volumeRatio":1.25997,"shares":227138828,"dividePrice":0,"high":0.145,"amplitude":0.068966,"preClose":0.145,"low":0.135,"week52Low":0.135,"pbRate":"0.63","psRate":"1.61","week52High":0.69,"institutionHeld":0,"latestPrice":0.14,"committee":-0.857209,"eps":-0.0887,"divideRate":0,"volume":67580,"delay":0,"ttmEps":-0.0887,"open":0.135,"prevYearClose":0.25,"prevWeekClose":0.145,"prevMonthClose":0.155,"prevQuarterClose":0.25,"fiveDayClose":0.14,"twentyDayClose":0.235,"sixtyDayClose":0.335,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609840445","title":"Genetic Signatures Ltd-Gss Appoints Anne Lockwood as Interim Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2609840445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609840445?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:20","pubTimestamp":1770326416,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nTUE1ZQZGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2608884292","title":"Genetic Signatures Ltd-Genetic Signatures Appoints Maria Halasz as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608884292?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:20","pubTimestamp":1769984422,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nTUE4DRHFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0},{"id":"2605146441","title":"Slammed 26% Genetic Signatures Limited (ASX:GSS) Screens Well Here But There Might Be A Catch","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605146441?lang=en_us&edition=fundamental","pubTime":"2026-01-23 04:31","pubTimestamp":1769113913,"startTime":"0","endTime":"0","summary":"Unfortunately for some shareholders, the Genetic Signatures Limited ( ASX:GSS ) share price has dived 26% in the last...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/slammed-26-genetic-signatures-limited-asxgss-screens-well-he","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/slammed-26-genetic-signatures-limited-asxgss-screens-well-he","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0},{"id":"2604166909","title":"BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2604166909","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604166909?lang=en_us&edition=fundamental","pubTime":"2026-01-20 12:55","pubTimestamp":1768884937,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signature hits record low on lower quarterly sales** Shares of Genetic Signatures GSS.AX down as much as 4.6% at its record low level of A$0.21** The molecular diagnostics firm posts Q2 FY26, sales of A$3.3 million , down from A$3.8 million a year ago** About 422,306 shares change hands, 3.7x 30-day average       ** Stock fell 60.3% in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL0B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2604415424","title":"BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2604415424","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604415424?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:06","pubTimestamp":1768871199,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Logs Q2 Sales Of A$3.3 MillionJan 20 (Reuters) - Genetic Signatures Ltd GSS.AX:Q2 SALES OF A$3.3 MILLIONFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2604153090","title":"Genetic Signatures Ltd - Q2 Sales of a$3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2604153090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604153090?lang=en_us&edition=fundamental","pubTime":"2026-01-20 05:21","pubTimestamp":1768857686,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GSS.AU","BK7501"],"gpt_icon":0},{"id":"2603024939","title":"We're Not Very Worried About Genetic Signatures' (ASX:GSS) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2603024939","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603024939?lang=en_us&edition=fundamental","pubTime":"2026-01-16 04:40","pubTimestamp":1768509655,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/were-not-very-worried-about-genetic-signatures-asxgss-cash-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/were-not-very-worried-about-genetic-signatures-asxgss-cash-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2591699384","title":"Genetic Signatures CEO to Step Down, Shares Fall 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591699384","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591699384?lang=en_us&edition=fundamental","pubTime":"2025-12-15 10:31","pubTimestamp":1765765899,"startTime":"0","endTime":"0","summary":"Genetic Signatures  said that its Chief Executive Officer, Allison Rossiter, informed the board that she will be leaving the firm in late February 2026 to take on a role with a global pharmaceutical firm, according to a Monday Australian bourse filing.Jenny Harry and Anne Lockwood will support the management team during the transition.Its shares fell 9% in recent trading on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2591693005","title":"BRIEF-Genetic Signatures Says CEO Allison Rossiter To Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2591693005","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591693005?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:25","pubTimestamp":1765761941,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Says CEO Allison Rossiter To LeaveDec 15 (Reuters) - Genetic Signatures Ltd GSS.AX:CEO ALLISON ROSSITER INFORMED BOARD OF LEAVINGFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XI0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0},{"id":"2591667380","title":"Genetic Signatures Ltd - CEO Allison Rossiter Informed Board of Leaving","url":"https://stock-news.laohu8.com/highlight/detail?id=2591667380","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591667380?lang=en_us&edition=fundamental","pubTime":"2025-12-15 06:28","pubTimestamp":1765751294,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nFWN3XI0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2582338506","title":"Genetic Signatures Chief Financial, Operating Officer Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2582338506","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582338506?lang=en_us&edition=fundamental","pubTime":"2025-11-11 10:09","pubTimestamp":1762826985,"startTime":"0","endTime":"0","summary":"Genetic Signatures (ASX:GSS) said its Chief Financial and Operating Officer, Karl Pechmann, resigned and he will leave his position effective Jan. 30, 2026, according to a Tuesday ASX filing.The firm said that interim arrangements will be put in place to ensure continuity of operations.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2582638754","title":"BRIEF-Genetic Signatures Announces Resignation Of CFO Karl Pechmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2582638754","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582638754?lang=en_us&edition=fundamental","pubTime":"2025-11-11 09:12","pubTimestamp":1762823555,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Announces Resignation Of CFO Karl PechmannNov 11 (Reuters) - Genetic Signatures Ltd GSS.AX:RESIGNATION OF CHIEF FINANCIAL OFFICERRESIGNATION OF CHIEF FINANCIAL AND OPERATING OFFICER KARL PECHMANNFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUE6KT2WV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","GSS.AU","BK7501"],"gpt_icon":0},{"id":"2582886153","title":"Genetic Signatures Ltd-Resignation of Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582886153","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582886153?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:21","pubTimestamp":1762809667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUE6KT2WV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","GSS.AU","BK7048"],"gpt_icon":0},{"id":"2582810893","title":"Even With A 26% Surge, Cautious Investors Are Not Rewarding Genetic Signatures Limited's (ASX:GSS) Performance Completely","url":"https://stock-news.laohu8.com/highlight/detail?id=2582810893","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582810893?lang=en_us&edition=fundamental","pubTime":"2025-11-09 06:32","pubTimestamp":1762641131,"startTime":"0","endTime":"0","summary":"Those holding Genetic Signatures Limited ( ASX:GSS ) shares would be relieved that the share price has rebounded 26% in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/even-with-a-26-surge-cautious-investors-are-not-rewarding-ge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/even-with-a-26-surge-cautious-investors-are-not-rewarding-ge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK4211","ISBC","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2581040241","title":"Genetic Signatures Updates CEO Remuneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2581040241","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581040241?lang=en_us&edition=fundamental","pubTime":"2025-11-07 08:51","pubTimestamp":1762476717,"startTime":"0","endTime":"0","summary":"Genetic Signatures  revised the remuneration package for Chief Executive Allison Rossiter, setting her base salary at AU$515,000 and introducing performance-based long-term incentives worth up to 25% of her salary, effective Oct. 1, according to a Friday filing with the Australian bourse.All other elements of her prior remuneration and termination arrangements remain unchanged, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2581204587","title":"Genetic Signatures Ltd-Chief Executive Officer Remuneration Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581204587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581204587?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:41","pubTimestamp":1762465278,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUEC3MTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0},{"id":"2577143568","title":"Genetic Signatures Reports Regional Success of EasyScreen Gastrointestinal Parasite Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=2577143568","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577143568?lang=en_us&edition=fundamental","pubTime":"2025-10-21 11:07","pubTimestamp":1761016059,"startTime":"0","endTime":"0","summary":"Genetic Signatures  has reported a strong start to the new financial year with the commercial success of its EasyScreen gastrointestinal parasite detection testing kit across all operating regions, and a 20% increase in sales for the quarter to $5.4 million.Revenue contributions came from new business with existing customers in Australia, which experienced higher testing rates due to the southern hemisphere winter.The company also saw a 52% increase in gastrointestinal testing across Europe, Middle East and Africa .Genetic Signatures signed its maiden commercial order in the US during the quarter, later adding a second with a large, non-profit integrated healthcare organisation, and a third post the rule-off date with a customer experience site—a deal the company expects to further enhance its market visibility.Net operating cash outflow for the quarter was $2.1 million, while net cash outflows of $400,000 included investments in new equipment for Genetic’s research and development lab","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Genetic-Signatures-ASX-GSS-Regional-Success-EasyScreen-Gastrointestinal-Parasite-Detection-Kit.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Genetic-Signatures-ASX-GSS-Regional-Success-EasyScreen-Gastrointestinal-Parasite-Detection-Kit.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/genetic-signatures-regional-success-easyscreen-gastrointestinal-parasite-detection-kit/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/genetic-signatures-regional-success-easyscreen-gastrointestinal-parasite-detection-kit/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7501","GSS.AU","BK7048"],"gpt_icon":0},{"id":"2577981195","title":"BUZZ-Australia's Genetic Signatures set for best day on sales growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2577981195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577981195?lang=en_us&edition=fundamental","pubTime":"2025-10-21 10:51","pubTimestamp":1761015108,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures set for best day on sales growth** Shares of Genetic Signatures GSS.AX rise as much as 58.3% to A$0.38, their highest level since July 23 and on track for best day ever** Specialist molecular diagnostics co reports quarterly sales of A$5.4 million , up 15% pcp** About 866,000 shares change hands, 5.7 times the 30-day avg** Stock down 39.7% YTD, including the session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL6N3W205S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2577815480","title":"BRIEF-Genetic Signatures Says Quarterly Sales Reach A$5.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2577815480","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577815480?lang=en_us&edition=fundamental","pubTime":"2025-10-21 09:34","pubTimestamp":1761010480,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Says Quarterly Sales Reach A$5.4 MillionOct 21 (Reuters) - Genetic Signatures Ltd GSS.AX:QUARTERLY SALES REACH A$5.4 MILLIONFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nTUE3SHCVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2577755896","title":"Genetic Signatures Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2577755896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577755896?lang=en_us&edition=fundamental","pubTime":"2025-10-21 05:31","pubTimestamp":1760995919,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUE3SHCVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}